RNA, U6 small nuclear 288, pseudogene (RNU6-288P)

RNU6-288P is a **non-coding pseudogene** derived from the U6 small nuclear RNA (snRNA) gene family. U6 snRNA is a well-characterized component of spliceosomes—cellular complexes responsible for excising introns from pre-mRNA during post-transcriptional modification in eukaryotes[1][2][3]. The genuine U6 snRNA is essential for splicing, acts at the catalytic core of the spliceosome, and is highly conserved across species, reflecting its fundamental biological importance[1][2][3]. U6 snRNA is typically transcribed by RNA polymerase III[3]. \n\nHowever, many **U6-derived pseudogenes (like RNU6-288P)** are present in the human genome[1]. These pseudogenes result from the duplication and subsequent loss of function of U6 snRNA genes during evolution. They are **not transcribed into functional RNA** and do not participate directly in any biological processes, disease mechanisms, or therapeutic interventions[1][3]. Their primary significance is evolutionary; they are regarded as genomic "back-ups" or remnants and do not interact with drugs or function as clinical biomarkers.\n\n**Key Considerations:**\n- The term "target" typically applies to functional gene products (receptors, enzymes, etc.) that can be modulated for therapeutic benefit. As a pseudogene, RNU6-288P does not meet these criteria.\n- If searching for a genuine therapeutic target related to U6 snRNA (e.g., in splicing), you should refer to **U6 small nuclear RNA** (not pseudogenes like RNU6-288P)[1][2][3].\n- There is no evidence that RNU6-288P itself, as a pseudogene, plays any role in disease, pharmacology, or treatment monitoring.\n\n**Summary:**\nRNU6-288P is a *pseudogene* of the U6 snRNA family, encoding no functional RNA or protein, and is not a valid therapeutic target[1][2][3]. If you require information about spliceosomal function or splicing machinery, focus on **U6 small nuclear RNA** rather than its pseudogenes.

Other names

RNU6-288PU6 snRNA pseudogene 288small nuclear RNA, U6, pseudogene 288